Original Article
Role of Mitomycin C Probing and Syringing in
Failed DCR (Dacrocystorhinostomy) Patients
Bakht Samar Khan, Abid
Nawaz, Maqbol-ur-Rehman
Pak J Ophthalmol 2018, Vol. 34, No. 3
. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. .
.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See
end of article for authors
affiliations …..……………………….. Correspondence
to: Bakht Samar Khan MBBS, DOMS, FCPS Associate professor Ophthalmology Unit Khyber Teaching Hospital,
Peshawar Email:
bsetbakht@yahoo.com |
Purpose: To
evaluate the role of 0.01% (0.1 mg/ml) Mitomycin C probing followed by
syringing with 0.1% MMC in failed DCR patients. Study
Design: Prospective cohort study. Place
and Duration of Study: from Jan 2014 to Dec 2015 at Department of
Ophthalmology, Khyber Teaching Hospital Peshawar. Material
and Methods: Thirty (30) patients, 19 females and 11 males of failed DCR were
included in the study. Patients with symptoms of epiphora and
positive/doubtful regurgitation test were included in the study. Exclusion
criteria were traumatic chronic dacryocysitis, history of failed DCR for more
than two weeks and nasal abnormality. Probing with Mitomycin C followed by
syringing and irrigation were done at presentation, at 6 weeks
interval, at 3 months interval and 6 months interval if needed. The procedure
was declared successful if saline came into the nose or throat. The patient
was prescribed topical antibiotic drops, saline nasal drops and saline
gargles. Each time ENT consultation was done to see the side effects of
mitomycin in throat and nose. Results:
All of the thirty patients included in the study showed
improvement in NLD patency after probing followed by syringing with MMC when
failed DCR was detected within first fifteen days of DCR. Conclusion:
If failed DCR patients are detected within fifteen days after surgery,
probing and syringing done with mitomycin C improves the patency of NLD
system. Keywords: Dacrocystorhinostomy, mitomycin c, probing
and syringing of lacrimal sac. |
DCR is done for epiphora due to nasolacrimal duct obstruction. If
epiphora and conjunctivitis persists after DCR surgery it is a troublesome
situation for patients. The reported failure rate after primary DCR procedure is
from 11 to 28%1.
Various options are used to manage these patients. These include
long-term medications to surgical intervention. After a successful patent DCR
operation, the causes of later failure include fibrosis at canalicular or
osteotomy site2,3. Even
intubation of lacrimal drainage system can have granulation tissue formation4,5. To prevent this complication some surgeons use anti fibrotic agent
Mitomycin C at these sites6,7. Mitomycin
C is a chemotherapeutic agent, which prevents fibrosis by inhibiting collagen
synthesis. Mitomycin was first used in ophthalmology in 1969 in recurrent pterygium.
Later, in filtration and DCR to prevent scarring8. Various types of application
and concentrations have been used with different routes. These include cotton
tip soaked in MMC application to nasal and lacrimal mucosa followed by
irrigation with normal saline. Kamal et al, used the technique of intramucosal
injection of 0.1ml of 0.02% MMC along the ostium called COS MMC9.
Long-term medication is just
symptomatic treatment with many side effects. Similarly, re-surgery does not
suit the surgeon or the patient. If
failure of DCR is detected in first fifteen days of surgery, it is possible to
treat by simple ways comparatively. In
this study, we have used a new technique of MMC probing followed by MMC
syringing. The role and effectiveness of mitomycin C probing and syringing is
highlighted.
MATERIAL
AND METHODS
This study was done in Eye B
unit of KTH/KMC. Exclusion criteria were traumatic chronic dacryocystitis,
history of failed DCR more than two weeks and nasal abnormality. A total of 30
patients with symptoms of epiphora and positive/doubtful regurgitation test
were included in the study. Patients were taken into OT. Patient’s consent was
taken and procedure was explained. Under topical anesthesia syringing with
diluted 0.5% lignocaine ( one ml of 2% xylocaine with four ml saline) done to
confirm the blockage or failure of DCR. Probing was done with lacrimal probe
soaked in 0.01% MMC. This was followed by syringing and irrigation with 0.1% MMC
mixed saline for ten minutes. After ten minutes interval the naso-lacrimal duct
drainage system was irrigated with normal saline. This process was repeated at
6 weeks, three months and six months interval. The procedure was declared
successful if saline came into the nose or throat. The patient was prescribed
topical antibiotic drops, saline nasal drops and saline gargles. Each time ENT
consultation was done to see the side effects of mitomycin in throat and nose.
As far as level of obstruction in different cases was concerned, our objective
was failure at any site.
RESULTS
The results were classified in
four phases (Table 1).
Phase 1
A total thirty patients of
recent DCR were identified and confirmed by syringing and irrigation method. In
all these patients on presentation probing and syringing with 0.01% MMC
solution were done. The result showed that 17 NLD were fully patent and 13 were
partially patent.
Phase 2
The technique was repeated at 6
weeks and it was found that 15 NLD were fully patent, 10 NLD had partial and 5
NLD had complete block. The procedure or technique of probing and irrigation
with mitomycin was repeated in all patients irrespective of patency. There were
20 NLD fully patent and 10 partially patent.
Phase 3
After three months interval again
the patency was checked. 18/30 patients had fully patent drainage system, 11/30
had partial and one completely blocked passage. Probing and syringing with Mitomycin
was done. All were patent with 19/30 fully patent and 11/30 partial.
Phase 4
The procedure was repeated after six months and it was found that
20/30 patients had patent NLD and 10/30 patients had partial blockage. (Partial
means some fluid into throat or nose and some fluid through upper or lower
punctum). All cases were followed for six months from date of patency noted.
Table 1: Summary of the procedure and results.
Syringing before Probing |
Syringing with MMC after Probing with MMC |
|||||
|
Patency Partial |
Patency Total |
Blocked |
Patency Partial |
Patency Total |
Blocked |
At Presentation |
0 |
0 |
30 (100%) |
13 (43%) |
17 (57%) |
0 |
At 6 Weeks |
10 (33%) |
15 (50%) |
5 (17%) |
10 (33%) |
20 (67%) |
0 |
At 3 Months |
11 (37%) |
18 (60%) |
1 (03%) |
11 (37%) |
19 (63%) |
0 |
At 6 Months |
10 (33%) |
20 (67%) |
0 |
10 (33%) |
20 (67%) |
0 |
DISCUSSION
DCR with or without intubation of drainage system is choice of
primary surgical standard procedure for NLD obstruction for age 7 years and
above. In spite of all surgical available techniques there is an average
failure rate of 9.4%10. The
causes of failure may help the surgeon in planning to exclude causes of failure
before or during operation. The major failure rate reported by Wilham and Wulc
is 32.21%. They reported the cause of failure as malposition of window and
scarring by anterior ethmoid air cells11.
Many authors have noted that the cause of failure is scarring or
fibrosis at canalicular system, osteotomy site or nasal septum site12,13,14. Performing second surgery
Pico found an occluding membrane at the site of drainage channel15. Scarring
is one of the key factors in failure of naso lacrimal drainage apparatus. Various
authors started to use MMC for prevention of failure in primary surgery.
As far as usage is concerned, You and Fang used different
concentration of mitomycin as 0.02% (0.2 mg/ml) MMC in one group and 0.05% (0.5
mg/ml) MMC in other group16. There was no statistical significance
of dose used. However, MMC increased the success rate over traditional DCR.
Deka et al used intraoperative MMC with 95% success rate17
and Mukhtar et al reported 97.5% success rate6. Postoperative MMC
soaked cotton ball swab was used intranasally by Henson et al with success rate
of 92.8%18. Feng CT al in their Meta analysis stated that intra
operative use of MMC is safe and increase the success rate after both primary
DCR and revision endo laser DCR16. Gupta et al did re surgical
intervention in failed DCR patients with success rate of 92.4%19.
In our study it was confirmed that MMC 0.01% (0.1mg/ml) helps in
patency even after post operative failure. As
far as dose and concentration is concerned, various authors have used different
concentration of MMC in various procedure of DCR to enhance the success rate of
surgery.
The dose concentration used as, 0.02% MMC and 0.05% MMC by You and Fang respectively.16 0.05% MMC and 0.4% MMC by Deka et al,17
0.02%MMC by Mukhter et al6. Various
concentration for different time period were used. The minimum effective
concentration 0.2 mg/ml for 3 minutes is more effective while in our study
0.01% (0.1 mg/ml) was equally effective. In another study, the dose of 0.02 to
0.04% for 5-30 minutes was successfully used with no complication20.
The Route used was intra
operative by You and Feng16, intra operative by Deka et al17,
Circum-ostial inj of mitomycian (COS-MMC) on nasal mucosa by Ari et al21. In our study
it was 0.01% (0.1 mg/ml). Route was probing with
MMC, syringing and irrigation with 0.01% MMC.
In various studies the success
rate in Qadir M et al was 96% with mitomycin C vs 80% without mitomycin.22
In Mukhter et al study, by using 0.02% (0.2 mg/ml) MMC success was 97.5%,6
in Deka et al 0.04% (0.4 mg/ml) it was 95%17. In Kamal et al all the
success rate was 97.3%.8 Otolaryngologist (ENT surgeon) used intraoperative
mitomycin C during endoscopic DCR surgery at 93.3% success rate vs 78.3% without
mitomycin C23. They all used MMC as intra operative in
primary procedure while in our study the concentration used was 0.01% (0.1 mg/ml)
MMC after failure of surgery. The success rate was 100% if failed DCR was detected
in first two weeks of surgery.
CONCLUSION
If failed DCR patients are
detected in first fifteen days after surgery, probing and syringing is done
with mitomycin C. It improves the
patency of NLD system.
Author’s
Affiliation
Dr.
Bakht Samar Khan
MBBS, DOMS, FCPS, Associate Professor
Ophthalmology Unit, Khyber
Teaching Hospital Peshawar.
Professor
Abid Nawaz
MBBS, DO, FRCS, Professor of
Ophthalmology
Kabir Medical College, Peshawar.
Maqbol-ur-Rehman
Post Graduate Trainee
Ophthalmology Department Khyber
Teaching Hospital, Peshawar.
Roles
of Authors
Dr. Bakht Samar Khan
Study Design, data collection,
analysis, result compilation and article writing.
Dr. Abid nawaz
Analysis, critical review.
Dr. Maqbol-ur-Rehman
Literature review, data
collection and reference collection.
REFERENCES
1.
Liao LS. Kao SCS. Tseng JHS, Chen MS, Hou PK. Results of intraoperative mitomycin C application in
dacryocystorhinostomy. Br J Ophthalmol. 2000; 84: 903-6.
2.
Karkos PD, Leong SC, Sastry A, Assimakopoulos AD, Swift AC. Evidence-based application of mitomycin C in the nose. Am J
Otolaryngol. 2011; 32: 422-5.
3.
Leong SC, Macewen CJ, White PS.
A systematic review of outcomes after dacryocystorhinostomy in adults. Am J
Rhinol Allergy, 2010; 24: 81-90.
4.
Agarwal S. Endoscopic
dacryocystorhinostomy for acquired nasolacrimal duct obstruction. J Laryngol
Otol. 2009; 123: 1226-8.
5.
Ozkiris M, Ozkiris A.
Endoscopic dacryocystorhinostomy not using canalicular silicone intubation tube
with and without mitomycin C: a comparative study. Eur J Ophthalmol. 2012; 22: 320-5.
6.
Mukhtar SA, Jamil AZ, Ali Z.
Efficacy of external dacryocystorhinostomy (DCR) with and without mitomycin C
in chronic dacryocystitis. J Coll Physicans Surg. Pak. 2014; 24: 732-5.
7.
Penttila E, Smirnov G, Seppa J, Kaarniranta K, Tuomilehto H. Mitomycin Cin revision endoscopic dacryocystorhinostomy: a
prospective randomized study. Am J Rhinol Allergy, 2011; 25: 425-8.
8.
Kunitomoro N, Mori S.
Studies on pterygium: Part 4, a treatment by Mitomycin-C installation. Acta Soc
Ophthalmol Jpn. 1969; 67: 601-7.
9.
Kamal S, Ali MJ, Naik MN.
Circumostial injection of mitomycin C (COS –MMC) in external endoscopic
dacryocystorhinostomy. Efficacy, safty profile, and outcome. Ophthalmic Plas
Reconconst Surg. 2014; 30: 187-90.
10.
Walland MJ, Rose GE.
Factors affecting the success rate of open lacrimal surgery. Br J Ophthalmol.
1994; 78: 881-91.
11.
Welham RAN, Wulc AE.
Management of unsuccessful lacrimal surgery. Br J ophtalmol. 1987; 71: 152-7.
12.
Hallum AV. The Dupuy-Dutemps dacryocystorhinostomy. Am J ophthalmol. 1949;
32: 1197-206.
13.
Mepherson TR, Egleston DB.
Dacryocystorhinostomy. Am J ophthalmol. 1959; 47: 328-31.
14.
Cheng SM, Feng YF, Xu L, Li Y, Haung JH. Efficacy of mitomycin Cin endoscopic dacryocystorhinostomy. A
systemic review and meta-analysis. PLOS One 2013, 8: e62737.
15.
PICO GA. A modified technique of
external dacryocystorhinostomy. Am J Ophthalmol. 1971; 72: 679-90.
16.
You YA, Feng CT.
Intra operative MMC in DCR, Ophthal plastic reconst Surf. 2001; 17: 115-9.
17.
Deka A, Bhattacharjee K, Bhuyan Sk, Barua CK, Bhattacharjee H,
Khaund G. Effect of mitomycin C on
ostium in dacryocystorhinostomy, clin experiment ophthalmol. 2006; 34: 557-61.
18.
Henson Rd, Cruz HL, Henson RG Jr, Ali Mj, Kakizaki H. Postoperative application of mitomycin C in endocanalicular laser
dacryocystorhinostomy. Ophthal plast reconstr surg. 2012; 24: 732-5.
19.
Gufta R, Gupta P, Kushwaha RN.
Failed DCR dealing with care to succeed. Sch J, app.med. Sci. 2320-6691; 2013.
20.
Kao SC, Liao CL, Tseng JH, Chen MS, Hou PK. Dacryocystorhinostomy with intraoperative mitomycin C.
Ophthalmology, 1997; 104: 86-91.
21.
Ari S, Gun R, Surmeli S, Atay AE, Caca I. Use of adjunctive mitomycin C in external dacryocystorhinostomy
surgery compared with gurgery alone in patients with nasolacrimal duct
obstruction: a prospective, double-masked, randomzed controlled trail. Curr
Ther res clin exp. 2009; 70: 267-73.
22.
Qadir M, Ahangar A, Dar MA, Hamid S, Keng MQ. Comparative study of dacryocystorhinostomy with and without
intraoperative application of Mitomycin C. Saudi Journal of Ophthalmology, 2014;
28: 44-48.
23.
Farooq MU, Ansari MA, Khyani IA.
Role of mitomycin C in endoscopic management of nasolacrimal duct obstruction.
J Dow Uni Health Sci. 2013; 7 (2): 63-67.